Major deals, including Johnson & Johnson’s $14.6B Intra-Cellular acquisition, signal renewed dealmaking, supported by nearly ...

Emergen Research Logo The Clinical Trial Logistics Market is expected to grow from an estimated USD 3915.5 million in 2024 to USD 8504.0 mi ...

Arquitos returned 29.6% net of fees and expenses in 2024, compared to 25.0% for the S&P 500. Click here to read the full ...

February 10-11: BIO CEO & Investor Conference 2025. Daniel Vitt, Ph.D., Chief Executive Officer of Immunic, will participate in one-on-one meetings at this conference, taking place in New York.

Clear Creek Financial Management LLC lifted its stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 57.6% during the fourth quarter, according to its most recent 13F filing with ...

Perigon Wealth Management LLC trimmed its stake in Lantern Pharma Inc. (NASDAQ:LTRN – Free Report) by 49.5% during the fourth quarter, according to its most recent 13F filing with the Securities and ...

Governor Maura Healey signed House Bill 5159 into law, toughening the rules and increasing the risks for private equity ...

The following is a summary of “Cost–consequence analysis of early vs. delayed natalizumab use in highly active ...

Q4 2024 Earnings Call Transcript February 4, 2025 Merck & Co., Inc. misses on earnings expectations. Reported EPS is $1.72 ...

Correspondence to Dr Thomas Bandholm, Dept of Clinical ... Data sharing is also expected by some non-private funding bodies.70 If you can share your trial data, there are some things that you may want ...